Effect of HPV16 L1 virus-like particles on the aggregation of non-functionalized gold nanoparticles

被引:13
|
作者
Palomino-Vizcaino, Giovanni [1 ]
Valencia Resendiz, Diana Gabriela [1 ]
Luisa Benitez-Hess, Maria [1 ]
Martinez-Acuna, Natalia [1 ]
Virginia Tapia-Vieyra, Juana [1 ]
Bahena, Daniel [2 ]
Diaz-Sanchez, Mauricio [3 ]
Patricio Garcia-Gonzalez, Octavio [3 ]
Arizai Alvarez-Sandoval, Brenda [3 ]
Marat Alvarez-Salas, Luis [1 ]
机构
[1] Dept Genet & Biol Mol, Lab Terapia Genica, Mexico City, DF, Mexico
[2] Inst Politecn Nacl, LANE, Ctr Invest & EstudiosAvanzados, Mexico City, DF, Mexico
[3] Genes2Life SAPI CV, R D & Innovat Dept, Guanajuato, Mexico
来源
关键词
Papillomavirus; Gold nanoparticles; Viral proteins; HPV; Virus-like particles; Molecular interaction; Binding; PROMISING PEROXIDASE MIMETICS; MAJOR CAPSID PROTEIN; HUMAN-PAPILLOMAVIRUS; HEPARAN-SULFATE; COLORIMETRIC DETECTION; BIOMEDICAL APPLICATIONS; H2O2; ADSORPTION; APTAMER; NANOCOMPOSITES;
D O I
10.1016/j.bios.2017.09.001
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Colorimetric assays based on gold nanoparticles (GNPs) are of considerable interest for diagnostics because of their simplicity and low-cost. Nevertheless, a deep understanding of the interaction between the GNPs and the intended molecular target is critical for the development of reliable detection technologies. The present report describes the spontaneous interaction between HPV16 L1 virus-like particles (VLPs) and non-functionalized GNPs (nfGNPs) resulting in the inhibition of nfGNPs salt-induced aggregation and the stabilization of purified VLPs. Ionic-competition experiments suggested that the nature of nfGNPs-VLPs interaction is non-covalent. Adsorption of an RNA aptamer on nfGNPs surface showed an additive aggregation-inhibitory effect. The use of mutant VLPs confirmed that the interaction nfGNPs-VLPs is not mediated by the opposing superficial electrostatic charges, suggesting that non-electrostatic forces participate in the arrangement of nfGNPs on the VLPs surface. Competition experiments using increasing ethanol concentrations on nfGNPs-VLPs complexes suggested hydrophobic interactions as the main stabilizing force. Therefore, the nfGNPs-VLPs interaction described here should facilitate the development of adsorption assays based on nfGNPs for HPV detection and cervical cancer prevention.
引用
收藏
页码:176 / 183
页数:8
相关论文
共 50 条
  • [21] Mucosal vaccination with a recombinant Salmonella typhimurium expressing human papillomavirus type 16 (HPV16) L1 virus-like particles (VLPs) or HPV16VLPs purified from insect cells inhibits the growth of HPV16-expressing tumor cells in mice
    Revaz, V
    Benyacoub, J
    Kast, WM
    Schiller, JT
    De Grandi, P
    Nardelli-Haefliger, D
    VIROLOGY, 2001, 279 (01) : 354 - 360
  • [22] Production of human papillomavirus type 16 L1 virus-like particles by recombinant Lactobacillus casei cells
    Aires, KA
    Cianciarullo, AM
    Carneiro, SM
    Villa, LL
    Boccardo, E
    Pérez-Martinez, G
    Perez-Arellano, I
    Oliveira, MLS
    Ho, PL
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2006, 72 (01) : 745 - 752
  • [23] Cytokine and chemokine profiles following vaccination with human papillomavirus type 16 L1 virus-like particles
    Garcia-Pineres, Alfonso
    Hildesheim, Allan
    Dodd, Lori
    Kemp, Troy J.
    Williams, Marcus
    Harro, Clayton
    Lowy, Douglas R.
    Schiller, John T.
    Pinto, Ligia A.
    CLINICAL AND VACCINE IMMUNOLOGY, 2007, 14 (08) : 984 - 989
  • [24] Antibodies to human papillomavirus 16 L1 virus-like particles as an independent prognostic marker in cervical cancer
    Heim, K
    Widschwendter, A
    Pirschner, G
    Wieland, U
    Awerkiew, S
    Christensen, ND
    Bergant, A
    Marth, C
    Höpfl, R
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2002, 186 (04) : 705 - 711
  • [25] Cervical secretory immunoglobulin A to human papillomavirus type 16 (HPV16) from HPV16-infected women inhibit HPV16 virus-like particles-induced hemagglutination of mouse red blood cells
    Rocha-Zavaleta, L
    Barrios, T
    Garciá-Carrancá, A
    Valdespino, V
    Cruz-Talonia, F
    FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2001, 31 (01): : 47 - 51
  • [26] Development of real-time RT-PCR for evaluation of JEV clearance during purification of HPV type 16 L1 virus-like particles
    Jeong, HS
    Shin, JH
    Park, YN
    Choi, JY
    Kim, YL
    Kim, BG
    Ryu, SR
    Baek, SY
    Lee, SH
    Park, SN
    BIOLOGICALS, 2003, 31 (03) : 223 - 229
  • [27] Visualization of discrete L1 oligomers in human papillomavirus 16 virus-like particles by gel electrophoresis with Coomassie staining
    Zhao, QJ
    Guo, HH
    Wang, Y
    Washabaugh, MW
    Sitrin, RD
    JOURNAL OF VIROLOGICAL METHODS, 2005, 127 (02) : 133 - 140
  • [28] Role of DC-SIGN in the activation of dendritic cells by HPV-16 L1 virus-like particle vaccine
    García-Piñeres, AJ
    Hildesheim, A
    Trivett, M
    Williams, M
    Wu, L
    KewalRamani, VN
    Pinto, LA
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2006, 36 (02) : 437 - 445
  • [29] Rectal and vaginal immunization of mice with human papillomavirus L1 virus-like particles
    Fraillery, Dominique
    Zosso, Nathalie
    Nardelli-Haefliger, Denise
    VACCINE, 2009, 27 (17) : 2326 - 2334
  • [30] Effects of downstream processing on structural integrity and immunogenicity in the manufacture of papillomavirus type 16 L1 virus-like particles
    Chang, Don Yong
    Kim, Hyoung Jin
    Kim, Hong-Jin
    BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2012, 17 (04) : 755 - 763